Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Regenerative Medical Technology (RMTG) Assets Average (2019 - 2025)

Historic Assets Average for Regenerative Medical Technology (RMTG) over the last 7 years, with Q3 2025 value amounting to $4.5 million.

  • Regenerative Medical Technology's Assets Average rose 4345.49% to $4.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year increase of 4345.49%. This contributed to the annual value of $3.4 million for FY2024, which is 3886.03% down from last year.
  • Per Regenerative Medical Technology's latest filing, its Assets Average stood at $4.5 million for Q3 2025, which was up 4345.49% from $4.2 million recorded in Q2 2025.
  • Regenerative Medical Technology's Assets Average's 5-year high stood at $14.0 million during Q3 2021, with a 5-year trough of $592204.0 in Q1 2021.
  • Its 5-year average for Assets Average is $6.2 million, with a median of $5.4 million in 2023.
  • Per our database at Business Quant, Regenerative Medical Technology's Assets Average skyrocketed by 1508518.51% in 2021 and then tumbled by 6309.89% in 2024.
  • Over the past 5 years, Regenerative Medical Technology's Assets Average (Quarter) stood at $13.2 million in 2021, then tumbled by 38.14% to $8.2 million in 2022, then crashed by 62.03% to $3.1 million in 2023, then increased by 13.82% to $3.5 million in 2024, then increased by 27.76% to $4.5 million in 2025.
  • Its Assets Average stands at $4.5 million for Q3 2025, versus $4.2 million for Q2 2025 and $3.9 million for Q1 2025.